Rensselaer researchers receive $3.5 million grant for development of COVID antiviral drug
TROY, N.Y. — Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from ...
TROY, N.Y. — Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from ...
ATLANTA—An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of ...
Interferons are proteins that constitute an important part of our natural defense systems. These proteins also exhibit a remarkable antiviral ...
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health awarded the UNC Gillings School of ...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $577 ...
Humans have developed four different IgG antibody subclasses that orchestrate protection against invading pathogens. A molecular and cellular understanding of ...
Pfizer’s oral antiviral drug (a combination of nirmatrelvir and ritonavir tablets) is strongly recommended for patients with non-severe covid-19 who ...
Photocatalyst made using a combination of titanium dioxide (TiO2) and copper oxide (CuxO) nanoclusters inactivates various variant types of novel ...
**Note: the release below is a special early release from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID ...
**Note: the release below is a special early release from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID ...
**Note: the release below is a special early release from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID ...
FDA has cleared the IND for S-217622, a once-daily investigational oral antiviral therapy, enabling the global phase 3 trial to ...
New York, NY—March 7, 2022—Researchers from Columbia Engineering, Fiocruz’s Center for Technological Development in Health and the Oswaldo Cruz Institute ...
The antiviral drug molnupiravir is conditionally recommended for patients with non-severe covid-19 who are at highest risk of hospitalisation, says ...
DETROIT (February 18, 2022) – Researchers at Henry Ford Health System, as part of a national hepatitis C collaborative, report ...
In a Perspective, Ronald Swanstrom and Raymond Schinazi argue that antiviral drugs that lead RNA viruses to produce genetic mutations ...
Credit: Georgia State University ATLANTA—The COVID-19 pandemic and resurgence of infections by other respiratory RNA viruses such as respiratory ...
OSAKA, Japan — In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease ...
A UBC-led research team has uncovered how the virus responsible for causing COVID-19 escapes destruction in infected cells, allowing SARS-CoV-2 ...
Researchers at the KU Leuven Rega Institute and CD3 have developed an ultrapotent inhibitor of the dengue virus, which causes ...
We bring you the latest science news from best research centers and universities around the world. Check our website.
© 2022 Scienmag- Science Magazine: Latest Science News.
© 2022 Scienmag- Science Magazine: Latest Science News.